MedScout vs. AcuityMD: What's the difference?

AcuityMD combines closed and open claims data with a built-in commercial platform so teams can run their full commercial motion in one place.

MedScout relies on simple LLM targeting queries that miss clinical context. AcuityAI provides a complete sales assistant that generates call plans, prepares audio briefs, plans territory trips, and recommends high-value next actions.

MedScout also lacks pipeline dollar tracking, contract management, and curated IDN and GPO rosters. AcuityMD delivers all three out of the box, backed by dedicated Customer Success support.

Yes, AcuityMD Pipeline tracks deals in dollar amounts, win rates, velocity, and activity history, giving teams a fuller view of performance than list-based tracking.

Yes. AcuityAI ships as a finished product with MedTech-specific skills, evals, and accuracy testing, with compliance guardrails built in, so it’s ready to use out of the box rather than requiring your team to build and maintain its own prompts on top of a general AI assistant.

Not yet. MedScout’s own help documentation states they are pursuing SOC 2 Type II certification. AcuityMD is certified today.

Yes, quarterly updates give you the best balance of recency and accuracy. Medicare data is only updated quarterly across the industry, so there's no faster option there. For commercial claims, the bottleneck is the adjudication process because a claim isn't final until it's closed out, and that takes time. Updating quarterly means you're working with data that's settled and accurate, rather than a monthly snapshot built on claims that are still in process and could still change.

On top of that, AcuityMD has Early Claims Signals, which gives you weekly alerts when an HCP on your targeting list starts billing a new code so you're not waiting a full quarter to catch an early sign of demand. It's the best of both worlds: accurate, settled data for your core analysis, plus a faster read on what's changing in between.